31 participants
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal Adenocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-11
- Start Date:
- 2026-09-08
- Completion:
- 2026-10-30
Conditions
- Advanced Pancreatic Ductal Adenocarcinoma
- Metastatic Pancreatic Ductal Adenocarcinoma
- Stage III Pancreatic Cancer AJCC v8
- Stage IV Pancreatic Cancer AJCC v8
- Unresectable Pancreatic Ductal Adenocarcinoma
Interventions
- PROCEDURE
- DRUG
- BIOLOGICAL
No Results Yet